UniProt ID | SPS2L_HUMAN | |
---|---|---|
UniProt AC | Q9NUQ6 | |
Protein Name | SPATS2-like protein | |
Gene Name | SPATS2L | |
Organism | Homo sapiens (Human). | |
Sequence Length | 558 | |
Subcellular Localization | Cytoplasm . Nucleus, nucleolus . During oxidative stress as well as UV irradiation, energy deprivation or heat shock, relocalizes to cytoplasmic stress granules. In the nucleus, found in structures lacking NPM1. | |
Protein Description | ||
Protein Sequence | MAELNTHVNVKEKIYAVRSVVPNKSNNEIVLVLQQFDFNVDKAVQAFVDGSAIQVLKEWNMTGKKKNNKRKRSKSKQHQGNKDAKDKVERPEAGPLQPQPPQIQNGPMNGCEKDSSSTDSANEKPALIPREKKISILEEPSKALRGVTEGNRLLQQKLSLDGNPKPIHGTTERSDGLQWSAEQPCNPSKPKAKTSPVKSNTPAAHLEIKPDELAKKRGPNIEKSVKDLQRCTVSLTRYRVMIKEEVDSSVKKIKAAFAELHNCIIDKEVSLMAEMDKVKEEAMEILTARQKKAEELKRLTDLASQMAEMQLAELRAEIKHFVSERKYDEELGKAARFSCDIEQLKAQIMLCGEITHPKNNYSSRTPCSSLLPLLNAHAATSGKQSNFSRKSSTHNKPSEGKAANPKMVSSLPSTADPSHQTMPANKQNGSSNQRRRFNPQYHNNRLNGPAKSQGSGNEAEPLGKGNSRHEHRRQPHNGFRPKNKGGAKNQEASLGMKTPEAPAHSEKPRRRQHAADTSEARPFRGSVGRVSQCNLCPTRIEVSTDAAVLSVPAVTLVA | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MAELNTHVN ------CCCCCCCCC | 29.95 | 19413330 | |
7 (in isoform 3) | Phosphorylation | - | 14.21 | 22210691 | |
8 (in isoform 3) | Phosphorylation | - | 9.19 | 22210691 | |
9 (in isoform 3) | Phosphorylation | - | 31.38 | 22210691 | |
15 | Phosphorylation | VNVKEKIYAVRSVVP CCHHHHEEEEEEECC | 15.31 | 28152594 | |
51 | Phosphorylation | VQAFVDGSAIQVLKE HHHHHCCHHHHHHHH | 20.10 | 27251275 | |
115 | Phosphorylation | MNGCEKDSSSTDSAN CCCCCCCCCCCCCCC | 36.94 | 23927012 | |
116 | Phosphorylation | NGCEKDSSSTDSANE CCCCCCCCCCCCCCC | 47.60 | 30266825 | |
117 | Phosphorylation | GCEKDSSSTDSANEK CCCCCCCCCCCCCCC | 39.94 | 30266825 | |
118 | Phosphorylation | CEKDSSSTDSANEKP CCCCCCCCCCCCCCC | 35.60 | 30266825 | |
120 | Phosphorylation | KDSSSTDSANEKPAL CCCCCCCCCCCCCCC | 32.84 | 30266825 | |
135 | Phosphorylation | IPREKKISILEEPSK CCHHHHEECCCCHHH | 29.96 | 23911959 | |
141 | Phosphorylation | ISILEEPSKALRGVT EECCCCHHHHHCCCH | 33.56 | 20068231 | |
148 (in isoform 2) | Phosphorylation | - | 40.79 | 29978859 | |
148 | Phosphorylation | SKALRGVTEGNRLLQ HHHHCCCHHHHHHHH | 40.79 | 20068231 | |
155 (in isoform 2) | Phosphorylation | - | 42.84 | 29978859 | |
159 | Phosphorylation | RLLQQKLSLDGNPKP HHHHHHCCCCCCCCC | 31.30 | 22617229 | |
170 | Phosphorylation | NPKPIHGTTERSDGL CCCCCCCCCCCCCCC | 16.01 | 27080861 | |
171 | Phosphorylation | PKPIHGTTERSDGLQ CCCCCCCCCCCCCCC | 33.71 | 27080861 | |
189 | Malonylation | EQPCNPSKPKAKTSP CCCCCCCCCCCCCCC | 52.36 | 26320211 | |
194 | Phosphorylation | PSKPKAKTSPVKSNT CCCCCCCCCCCCCCC | 43.02 | 26657352 | |
195 | Phosphorylation | SKPKAKTSPVKSNTP CCCCCCCCCCCCCCC | 27.30 | 25849741 | |
199 | Phosphorylation | AKTSPVKSNTPAAHL CCCCCCCCCCCCCEE | 46.28 | 23927012 | |
201 | Phosphorylation | TSPVKSNTPAAHLEI CCCCCCCCCCCEEEE | 22.77 | 23927012 | |
234 | Phosphorylation | DLQRCTVSLTRYRVM HHHHHHEEEEEEEEE | 13.08 | 24719451 | |
279 | Ubiquitination | MAEMDKVKEEAMEIL HHHHHHHHHHHHHHH | 56.42 | - | |
279 | 2-Hydroxyisobutyrylation | MAEMDKVKEEAMEIL HHHHHHHHHHHHHHH | 56.42 | - | |
300 | Phosphorylation | AEELKRLTDLASQMA HHHHHHHHHHHHHHH | 32.76 | 22210691 | |
304 | Phosphorylation | KRLTDLASQMAEMQL HHHHHHHHHHHHHHH | 27.99 | 22210691 | |
319 | Acetylation | AELRAEIKHFVSERK HHHHHHHHHHHHHHH | 23.61 | 26051181 | |
319 | Ubiquitination | AELRAEIKHFVSERK HHHHHHHHHHHHHHH | 23.61 | - | |
333 | Acetylation | KYDEELGKAARFSCD HCHHHHHHHHHHCCC | 52.04 | 26051181 | |
333 | Ubiquitination | KYDEELGKAARFSCD HCHHHHHHHHHHCCC | 52.04 | - | |
338 | Phosphorylation | LGKAARFSCDIEQLK HHHHHHHCCCHHHHH | 12.82 | 30266825 | |
345 | Methylation | SCDIEQLKAQIMLCG CCCHHHHHHHHHHHH | 37.63 | 23644510 | |
353 | Methylation | AQIMLCGEITHPKNN HHHHHHHCCCCCCCC | 43.66 | - | |
361 | Phosphorylation | ITHPKNNYSSRTPCS CCCCCCCCCCCCCHH | 19.88 | 21712546 | |
362 | Phosphorylation | THPKNNYSSRTPCSS CCCCCCCCCCCCHHH | 18.57 | 25159151 | |
363 | Phosphorylation | HPKNNYSSRTPCSSL CCCCCCCCCCCHHHH | 29.79 | 25627689 | |
365 | Phosphorylation | KNNYSSRTPCSSLLP CCCCCCCCCHHHHHH | 30.51 | 26657352 | |
368 | Phosphorylation | YSSRTPCSSLLPLLN CCCCCCHHHHHHHHH | 25.81 | 27251275 | |
369 | Phosphorylation | SSRTPCSSLLPLLNA CCCCCHHHHHHHHHH | 40.41 | 25394399 | |
380 | Phosphorylation | LLNAHAATSGKQSNF HHHHHHHCCCCCCCC | 38.50 | 20860994 | |
381 | Phosphorylation | LNAHAATSGKQSNFS HHHHHHCCCCCCCCC | 38.99 | 25159151 | |
385 | Phosphorylation | AATSGKQSNFSRKSS HHCCCCCCCCCCCCC | 43.24 | 22798277 | |
391 | Phosphorylation | QSNFSRKSSTHNKPS CCCCCCCCCCCCCCC | 39.08 | 26657352 | |
392 | Phosphorylation | SNFSRKSSTHNKPSE CCCCCCCCCCCCCCC | 36.40 | 26657352 | |
393 | Phosphorylation | NFSRKSSTHNKPSEG CCCCCCCCCCCCCCC | 36.24 | 24275569 | |
398 | Phosphorylation | SSTHNKPSEGKAANP CCCCCCCCCCCCCCH | 61.67 | 24275569 | |
409 | Phosphorylation | AANPKMVSSLPSTAD CCCHHHHHCCCCCCC | 23.74 | 18767875 | |
410 | Phosphorylation | ANPKMVSSLPSTADP CCHHHHHCCCCCCCC | 32.65 | 23312004 | |
413 | Phosphorylation | KMVSSLPSTADPSHQ HHHHCCCCCCCCCCC | 41.33 | 28857561 | |
414 | Phosphorylation | MVSSLPSTADPSHQT HHHCCCCCCCCCCCC | 32.89 | 23312004 | |
418 | Phosphorylation | LPSTADPSHQTMPAN CCCCCCCCCCCCCCC | 28.86 | 28857561 | |
421 | Phosphorylation | TADPSHQTMPANKQN CCCCCCCCCCCCCCC | 21.50 | 23312004 | |
430 | Phosphorylation | PANKQNGSSNQRRRF CCCCCCCCCHHHHCC | 33.39 | 20860994 | |
431 | Phosphorylation | ANKQNGSSNQRRRFN CCCCCCCCHHHHCCC | 38.08 | 20860994 | |
441 | Phosphorylation | RRRFNPQYHNNRLNG HHCCCHHHCCCCCCC | 14.05 | - | |
451 | Methylation | NRLNGPAKSQGSGNE CCCCCCCCCCCCCCC | 46.58 | - | |
451 | Ubiquitination | NRLNGPAKSQGSGNE CCCCCCCCCCCCCCC | 46.58 | - | |
452 | Phosphorylation | RLNGPAKSQGSGNEA CCCCCCCCCCCCCCC | 41.71 | 29255136 | |
455 | Phosphorylation | GPAKSQGSGNEAEPL CCCCCCCCCCCCCCC | 30.70 | 29255136 | |
464 | Methylation | NEAEPLGKGNSRHEH CCCCCCCCCCCCCCC | 63.70 | - | |
467 | Phosphorylation | EPLGKGNSRHEHRRQ CCCCCCCCCCCCCCC | 43.62 | 28857561 | |
493 | Phosphorylation | GAKNQEASLGMKTPE CCCCHHHCCCCCCCC | 25.38 | 25850435 | |
498 | Phosphorylation | EASLGMKTPEAPAHS HHCCCCCCCCCCCCC | 19.91 | 25159151 | |
505 | Phosphorylation | TPEAPAHSEKPRRRQ CCCCCCCCCCCCHHH | 49.80 | 28555341 | |
507 | Acetylation | EAPAHSEKPRRRQHA CCCCCCCCCCHHHHC | 47.00 | 26051181 | |
517 | Phosphorylation | RRQHAADTSEARPFR HHHHCCCCCCCCCCC | 24.60 | 23403867 | |
518 | Phosphorylation | RQHAADTSEARPFRG HHHCCCCCCCCCCCC | 29.79 | 23403867 | |
524 | Methylation | TSEARPFRGSVGRVS CCCCCCCCCCCCCHH | 38.88 | - | |
526 | Phosphorylation | EARPFRGSVGRVSQC CCCCCCCCCCCHHCC | 19.69 | 21955146 | |
531 | Phosphorylation | RGSVGRVSQCNLCPT CCCCCCHHCCCCCCC | 27.88 | 22617229 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of SPS2L_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SPS2L_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SPS2L_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
CUX1_HUMAN | CUX1 | physical | 26496610 | |
CASP_HUMAN | CUX1 | physical | 26496610 | |
RPGF1_HUMAN | RAPGEF1 | physical | 26496610 | |
SET_HUMAN | SET | physical | 26496610 | |
PLXA3_HUMAN | PLXNA3 | physical | 26496610 | |
USMG5_HUMAN | USMG5 | physical | 26496610 | |
SGO2_HUMAN | SGOL2 | physical | 26496610 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-120, AND MASSSPECTROMETRY. |